The American laboratory Pfizer and the German pharmaceutical company BioNtech unveiled, on March 31, the results of their clinical trial in 12-15 year olds. How effective is the Pfizer / BioNtech vaccine against Covid-19 in adolescents?
“100% efficiency”
Phase 3 clinical trials involved 2,260 adolescents in the United States. The results are conclusive, since the Pfizer / BioNtech duo announces in a press release: “ They have demonstrated 100% efficacy and robust antibody responses “. The two companies now hope ” start vaccinating this age group before the start of the next school year », As declared Albert Bourla, the general manager of the American group. Moreover, these results are “ very encouraging given the trends observed in recent weeks », Especially because of the spread of the English variant.
At the same time, the Pfizer / BioNtech duo launched clinical studies in different groups of children, aged 6 months to 2 years, 2 to 5 years and 5 to 11 years.
In France, the health authorities have not yet given their agreement to vaccinate children and adolescents against Covid-19.
